← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nirsum Laboratories, Inc.
New York, NY
$25,176,991
Total funding
3
Grants
Funding over time
peak $7.8M · FY2019–25$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,176,991 · 3
By mechanism
U01$9,732,775 · 1
UH3$9,160,866 · 1
UG3$6,283,350 · 1
Investigators at Nirsum Laboratories, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder$4,947,774
U01 · FY2025 · DA
Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder$4,785,001
U01 · FY2024 · DA
Development of a novel drug for treating opioid use disorder$3,060,540
UG3 · FY2019 · DA
Development of a novel drug for treating opioid use disorder$3,058,678
UG3 · FY2020 · DA
Development of a novel drug for treating opioid use disorder$3,056,516
UH3 · FY2022 · DA
Development of a novel drug for treating opioid use disorder$3,052,891
UH3 · FY2023 · DA
Development of a novel drug for treating opioid use disorder$3,051,459
UH3 · FY2024 · DA
Development of a novel drug for treating opioid use disorder$164,132
UG3 · FY2021 · DA